Evidence map›Paper›PMID 9294105›Full record

ArticleThe Journal of clinical investigation1997

Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.

T Lindner, C Gragnoli, H Furuta, B N Cockburn, C Petzold, H Rietzsch, U Weiss, J Schulze, G I Bell

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Crosstalk of HNF4Acta pharmaceutica Sinica. B · 2016
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Pancreatic function in carboxyl-ester lipase knockout mice.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2010
    Article
  13. Article
  14. Review
  15. Genetic epidemiology of diabetes.The Journal of clinical investigation · 2005
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

T LindnerHoward Hughes Medical Institute, Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA.
C Gragnoli
H Furuta
B N Cockburn
C Petzold
H Rietzsch
U Weiss
J Schulze
G I Bell
Howard Hughes Medical Institute · USUniversity Hospital Carl Gustav Carus · DETechnische Universität Dresden · DE

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
NIDDK NIH HHS DK-20595PHS HHS 47486
6 · The paper itself

Abstract

Maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic disorder characterized by autosomal dominant inheritance, onset usually before 25 yr of age, and abnormal pancreatic beta-cell function. Mutations in the hepatocyte nuclear factor(HNF)-4alpha/MODY1, glucokinase/MODY2, and HNF-1alpha/MODY3 genes can cause this form of diabetes. In contrast to the glucokinase and HNF-1alpha genes, mutations in the HNF-4alpha gene are a relatively uncommon cause of MODY, and our understanding of the MODY1 form of diabetes is based on studies of only a single family, the R-W pedigree. Here we report the identification of a second family with MODY1 and the first in which there has been a detailed characterization of hepatic function. The affected members of this family, Dresden-11, have inherited a nonsense mutation, R154X, in the HNF-4alpha gene, and are predicted to have reduced levels of this transcription factor in the tissues in which it is expressed, including pancreatic islets, liver, kidney, and intestine. Subjects with the R154X mutation exhibited a diminished insulin secretory response to oral glucose. HNF-4alpha plays a central role in tissue-specific regulation of gene expression in the liver, including the control of synthesis of proteins involved in cholesterol and lipoprotein metabolism and the coagulation cascade. Subjects with the R154X mutation, however, showed no abnormalities in lipid metabolism or coagulation except for a paradoxical 3.3-fold increase in serum lipoprotein(a) levels, nor was there any evidence of renal dysfunction in these subjects. The results suggest that MODY1 is primarily a disorder of beta-cell function.

Indexed as

DNA-Binding ProteinsMutationAdultBase SequenceBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBlood GlucoseC-PeptideDiabetes Mellitus, Type 2FemaleGermanyGlucose Tolerance TestHepatocyte Nuclear Factor 4HumansInsulinIslets of LangerhansKidneyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBlood GlucoseC-PeptideDNA-Binding ProteinsHepatocyte Nuclear Factor 4HNF4A protein, humanInsulinMLX protein, humanPhosphoproteinsProinsulinTranscription Factors

Identifiers

PMID9294105
PMCPMC508318
OpenAlexW1983340367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.